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Abstract
Background: In Australia, significant disparity persists in stillbirth rates between Aboriginal and Torres Strait Islander
(Indigenous Australian) and non-Indigenous women. Diabetes, hypertension, antepartum haemorrhage and small-
for-gestational age (SGA) have been identified as important contributors to higher rates among Indigenous women.
The objective of this study was to examine gestational age specific risk of stillbirth associated with these conditions
among Indigenous and non-Indigenous women.
Methods: Retrospective population-based study of all singleton births of at least 20 weeks gestation or at least
400 grams birthweight in Queensland between July 2005 and December 2011 using data from the Queensland
Perinatal Data Collection, which is a routinely-maintained database that collects data on all births in Queensland.
Multivariate logistic regression was used to calculate adjusted odds ratios (aOR) and 95 % confidence intervals,
adjusting for maternal demographic and pregnancy factors.
Results: Of 360987 births analysed, 20273 (5.6 %) were to Indigenous women and 340714 (94.4 %) were to
non-Indigenous women. Stillbirth rates were 7.9 (95 % CI 6.8–9.2) and 4.1 (95 % CI 3.9–4.3) per 1000 births,
respectively. For both Indigenous and non-Indigenous women across most gestational age groups, antepartum
haemorrhage, SGA, pre-existing diabetes and pre-existing hypertension were associated with increased risk of
stillbirth. There were mixed results for pre-eclampsia and eclampsia and a consistently raised risk of stillbirth was
not seen for gestational diabetes.
Conclusion: This study highlights gestational age specific stillbirth risk for Indigenous and non-Indigenous
women; and disparity in risk at term gestations. Improving access to and utilisation of appropriate and responsive
healthcare may help to address disparities in stillbirth risk for Indigenous women.
Keywords: Aboriginal and Torres Strait Islander Australians, Indigenous, Fetal death, Stillbirth, Risk, Diabetes,
Hypertension, Antepartum haemorrhage, Small for gestational age
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Background
Stillbirth rates in Australia have failed to improve over
the past two decades. Marked disparity in stillbirth rates
persist between Aboriginal and Torres Strait Islander
(Indigenous Australian) and non-Indigenous women
[1–3]. In 2012, national stillbirth rates among Indigenous
women were one and a half times higher (10.8 vs 7.1/
1000) than among non-Indigenous women [2]. Moreover,
this disparity persists in the rate of term stillbirths (RR
1.71, 95 % CI 1.40-2.09) with little change over time [1].
Diabetes, hypertension, antepartum haemorrhage and
small-for-gestational age are important contributors to
the higher stillbirth rates observed among Indigenous
women [1]. In Queensland, pre-existing and gestational
diabetes affected approximately 0.6 and 6.7 % of preg-
nancies [2]; while Australian national estimates are 0.6
and 4.7 %, respectively [4]. There is evidence of increas-
ing prevalence of pre-existing and gestational diabetes
within Queensland [2, 5]; with consistently higher rates
of diabetes for Indigenous women compared with non-
Indigenous women [4]. However, larger increases in the
prevalence of gestational diabetes have been reported
for non-Indigenous women [6]. Hypertensive disorders
of pregnancy (including pre-existing and pregnancy-
induced hypertension) affect around 0.6 and 4.4 % of
pregnancies in Queensland [2]. Antepartum haemorrhage
(including placenta praevia and abruption) is associated
with up to 20 % of very preterm births [7] and affects
2.4 % of pregnancies in Queensland [2]. Indigenous
women have higher rates of small-for-gestational age
births than non-Indigenous women [8].
Given the contribution of these conditions to still-
birth rates and the disproportionate burden among dis-
advantaged groups, determining the specific periods of
increased risk of stillbirth associated with these condi-
tions is important for clinical management and potential
further reductions in stillbirth rates. The objective of this
study was to examine the gestational age-specific risk of
stillbirth associated with antepartum haemorrhage, hyper-
tension, diabetes and small-for-gestational age among
Indigenous and non-Indigenous women in Queensland to
determine if there are differential effects of risk factors.
Methods
We conducted a population-based study utilising data
from the Queensland Perinatal Data Collection (QPDC)
for the period July 2005 to December 2011. The QPDC
is an administrative database which holds data on all
births occurring in Queensland. It is a requirement that
all births in Queensland are registered in the QPDC for
administrative purposes [9].
Demographic factors assessed included maternal
Indigenous status, age, marital status, socioeconomic sta-
tus and geographic location. Indigenous status was based
on maternal self-identification as Aboriginal or Torres
Strait Islander or not. Relative socioeconomic disadvan-
tage (based on residential postcode) was defined as
residing in the lowest ranked 20 % of neighbourhoods.
Geographic location (based on residential postcode)
was classified as major city, regional or remote. Pregnancy
factors assessed included smoking status, substance use,
hospital accommodation status, assisted conception use,
primigravidity, number of antenatal care visits, gestational
age at birth, baby’s sex and small-for-gestational age
(SGA). SGA was defined as birthweight less than the
10th Australian population percentile by gestational age,
plurality and sex [10].
Medical conditions of interest included: antepartum
haemorrhage, essential hypertension, pre-eclampsia/
eclampsia, gestational and pre-existing diabetes. Unfor-
tunately, we were unable to assess the effect of over-
weight/obesity over the study duration. Midwives, who
are directly involved in the clinical care of the individ-
ual mothers, provide the data to the QPDC. Data audits
completed in other Australian states show that false
positives and false negatives are generally <5 % for dia-
betes, hypertensive disorders and antepartum haemor-
rhage [11]. Stillbirth was defined as fetal death of at
least 20 weeks gestation or 400 g birthweight. Stillbirths
as a result of terminations of pregnancy for maternal
psychosocial reasons, births of unknown maternal Indi-
genous status or gestational age, births less than
20 weeks and less than 400 g birthweight, and births
with a congenital anomaly were excluded.
Statistical analysis
The all-cause conditional probability of stillbirth occur-
ring at each gestational age interval was calculated
using the number of stillbirths occurring within each
gestational age interval as the numerator and the num-
ber of ongoing pregnancies minus half the number of
births occurring within the gestational age interval as
the denominator [12].
Risk ratios were used to quantify the unadjusted risk
of stillbirth relative to livebirth associated with the con-
ditions of interest (diabetes, hypertension, antepartum
haemorrhage and small-for-gestational age). The adjusted
stillbirth risk for each of the conditions of interest was
assessed in four gestational age intervals of four weeks
and an interval of 37 weeks or more using multivariate lo-
gistic regression. Regression models were adjusted for the
previously listed demographic and pregnancy factors. The
denominator was adjusted to reflect the population-at-risk
(i.e. the number of ongoing pregnancies at the start of the
gestational age interval of interest). Analysis was stratified
by maternal Indigenous status, as we hypothesised that
differences would be observed in stillbirth risk between
Indigenous and non-Indigenous women, furthermore,
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both groups of women differed significantly on a num-
ber of demographic and pregnancy factors. Similar
patterns in stillbirth risk were found across strata of
antepartum/intrapartum and unknown stillbirth, there-
fore, to maintain sample size results are presented for
all stillbirths combined. Secondary analysis was under-
taken on the whole population (Indigenous and non-
Indigenous women combined) to assess stillbirth risk
among Indigenous women relative to non-Indigenous
women. Statistical analyses were performed using
Stata/SE for Windows 13.1 (StataCorp LP, College
Station, TX, USA 2013). Ethics approval was obtained
from the Queensland Health Central Office (Ref: HREC/
05/QHC/009), University of Queensland School of
Public Health (Ref: II180313) and Mater Health Services
(Ref: HREC/15/MHS/36/AM07) Human Research Ethics
Committees.
Results
The characteristics of the study population are sum-
marised in Table 1. A total of 360,987 births were in-
cluded in the analyses. Of these, 20,273 (5.6 %) births
were to Indigenous women and 340,714 (94.4 %) were
to non-Indigenous women. The stillbirth rates were 7.9
(95 % CI 6.8–9.2) and 4.1 (95 % CI 3.9–4.3) per 1000
births, respectively; giving a risk ratio of 1.9 (95 % CI
1.6–2.3). For Indigenous and non-Indigenous women,
there were higher rates of smoking, substance use, pre-
term birth and fewer than eight antenatal care visits
among women with a stillbirth compared to women
with a live birth (Additional file 1: Table S1). Among
non-Indigenous women, there were higher rates of
socioeconomic disadvantage (risk ratio 1.18, 95 % CI
1.03–1.35) for women with a stillbirth (Additional file
1: Table S1).
Table 2 shows birth outcomes for the study population.
For Indigenous and non-Indigenous women, there were
higher rates of pre-existing diabetes, pre-existing hyper-
tension, antepartum haemorrhage and SGA among
women with a stillbirth compared to women with a live
birth (Table 2). However, there were significant differences
in the prevalence of the conditions of interest between
Indigenous and non-Indigenous women, respectively as
follows: pre-existing diabetes (1.3 % vs 0.5 %, p < 0.001),
gestational diabetes (6.6 % vs 5.3 %, p < 0.001), pre-existing
hypertension (1.0 % vs 0.7 %, p < 0.001), pre-eclampsia/
eclampsia (2.9 % vs 2.2 %, p < 0.001), antepartum haemor-
rhage (2.3 % vs 2.7 %, p < 0.001) and small-for-gestational
age (15.2 % vs 8.4 %, p < 0.001).
The all-cause stillbirth risk profile for Indigenous and
non-Indigenous women was characterised by lower rates
of stillbirth at gestational ages before 38 weeks (0.2 to
0.6/1000 and 0.1 to 0.3/1000 ongoing pregnancies for
Indigenous and non-Indigenous women, respectively). A
marked increase in risk was then observed from 39 weeks
onwards, with a two-fold or higher risk for Indigenous
women compared with non-Indigenous women (Fig. 1).
Overall, women with a stillbirth were more likely to
have: pre-existing diabetes (2.1 % vs 0.5 %, risk ratio
3.92, 95 % CI 2.79–5.51), pre-existing hypertension
(2.5 % vs 0.7 %, risk ratio 3.70, 95 % CI 2.70–5.08), pre-
eclampsia/eclampsia (5.3 % vs 2.2 %, risk ratio 2.39,
95 % CI 1.94–2.96), antepartum haemorrhage (24.6 %
vs 2.6 %, risk ratio 9.43, 95 % CI 8.62–10.3) and a small
for gestational age infant (30.5 % vs 8.7 %, risk ratio
3.47, 95 % CI 3.21–3.75), while women with gestational
diabetes (4.0 % vs 5.4 %, risk ratio 0.74, 95 % CI 0.58–
0.94) or pregnancy-induced hypertension (1.8 % vs 2.9 %,
Table 1 Maternal and pregnancy characteristics by livebirth or
stillbirth and Indigenous status
Characteristics Indigenous
(n = 20 273)
Non-Indigenous
(n = 340 714)
Maternal age (years)
≤ 18 years 1 454 (7.2) 4 402 (1.3)
19–24 years 8 765 (43.2) 67 896 (19.9)
25–30 years 5 693 (28.1) 119 253 (35.0)
31–34 years 2 427 (12.0) 81 322 (23.9)
≥ 35 years 1 934 (9.5) 67 841 (19.9)
Geographic location
Major City 4 169 (20.6) 209 778 (61.6)
Regional area 11 920 (58.8) 122 590 (36.0)
Remote area 4 184 (20.6) 8 334 (2.5)
Marital status
Domestic partner 13 033 (64.3) 302 212 (88.7)
No domestic partner 7 232 (35.7) 38 452 (11.3)
Relative socioeconomic disadvantage
Lowest 20 % 7 422 (36.7) 39 503 (11.6)
Any smoking during pregnancy
Yes 10 692 (53.1) 56 720 (16.7)
Substance Use during pregnancy
Yes 343 (1.7) 1 705 (0.5)
Hospital accommodation status
Public 19 853 (97.9) 229 717 (67.4)
Assisted conception
Yes 92 (0.5) 12 909 (3.8)
Primigravidity
Yes 4 834 (23.8) 102 091 (30.0)
Number of antenatal care visits
Less than 2 1 102 (5.4) 2 291 (0.7)
2 – 4 3 405 (16.8) 17 349 (5.1)
5 – 7 5 828 (28.8) 63 386 (18.6)
8 or more 9 911 (49.0) 257 496 (75.6)
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risk ratio 0.62, 95 % CI 0.43–0.90) were less likely to have
a stillbirth.
Gestational age-specific odds of stillbirth are presented
by condition for Indigenous and non-Indigenous women
separately in Table 3; and for the whole population in
Additional file 1: Table S2. Additional file 1: Table S3
shows the odds of stillbirth by condition of interest for
Indigenous women relative to non-Indigenous women.
Diabetes
There were significantly increased odds of stillbirth associ-
ated with pre-existing diabetes from 33 weeks onwards for
both groups of women. Among Indigenous women, the
odds of stillbirth at 33–36 and 37+ weeks were aOR 19.0
(95 % CI 5.3–68) and aOR 15.4 (95 % CI 4.8–49), respect-
ively. Among non-Indigenous women, the adjusted odds
ratios for the equivalent gestational ages were 7.7 (95 % CI
3.4–17.6) and 6.8 (95 % CI 3.5–13.2) (Table 3). There was
a suggestion of increased odds of stillbirth associated with
gestational diabetes from 33 weeks onwards among non-
Indigenous women. There were decreased odds of still-
birth associated with diabetes at gestational ages less than
28 weeks for Indigenous women, but increased odds at
term (Additional file 1: Table S3).
Hypertension
There was a suggestion of increased odds of stillbirth as-
sociated with pre-existing hypertension at all gestational
Table 2 Maternal medical and pregnancy conditions by livebirth or stillbirth and Indigenous status
Characteristics Indigenous (n = 20273) Non-indigenous (n = 340714)
Stillbirth
(n = 160)
Livebirth
(n = 20113)
Risk Ratio
(95 % CI)
Stillbirth
(n = 1392)
Livebirth
(n = 339322)
Risk Ratio
(95 % CI)
Preterm birth 56 (35.0) 53 (0.3) 132 (94.3–187) 451 (32.4) 243 (0.1) 453 (391–525)
Pre-existing diabetes 12 (7.5) 248 (1.2) 6.08 (3.48–10.6) 21 (1.5) 1 702 (0.5) 3.01 (1.96–4.61)
Gestational diabetes a 1 324 (6.6) 0.38 (0.14–1.00) 58 (4.2) 18 135 (5.3) 0.78 (0.61–1.00)
Pre-existing hypertension 7 (4.4) 190 (0.9) 4.63 (2.21–9.69) 31 (2.2) 2 189 (0.7) 3.45 (2.43–4.90)
Pre-eclampsia/Eclampsia a 574 (2.9) 1.10 (0.46–2.60) 77 (5.5) 7 359 (2.2) 2.55 (2.05–3.17)
Pregnancy induced hypertension a 488 (2.4) 0.26 (0.04–1.82) 27 (1.9) 9 897 (2.9) 0.67 (0.46–0.97)
Antepartum haemorrhage 44 (27.5) 412 (2.0) 13.4 (10.3–17.6) 337 (24.2) 8 948 (2.6) 9.18 (8.35–10.1)
Small-for-gestational age 58 (36.3) 3 021 (15.0) 2.46 (2.00–3.02) 410 (29.5) 28 214 (8.3) 3.58 (3.30–3.89)
aNumbers and percentages not displayed for cells with five or less observations to protect participant privacy
ICD10-AM codes: Antepartum haemorrhage (O44.1, O45-O46), Pre-existing hypertension (O10.0, O10.2-10.4, O10.9, O11), Pregnancy Induced hypertension (O13),
Pre-eclampsia/Eclampsia (O14, O15), Pre-existing diabetes (O24.0, O24.1, O24.3, O24.8), Gestational diabetes (O24.4, O24.9)
Small-for-gestational age = birthweight less than the 10th Australian population percentile for gestational age, plurality and sex
Fig. 1 Gestational age specific risk of stillbirth by Indigenous status. Numerator = the number of stillbirths occurring at each week of gestational
age. Denominator = the number of ongoing pregnancies at each gestational age week minus half the number of births occurring within the
gestational age week
Ibiebele et al. BMC Pregnancy and Childbirth  (2016) 16:159 Page 4 of 8
ages assessed. Pre-eclampsia/eclampsia was likely to be
associated with increased odds of stillbirth for both
groups of women, although numbers were too small in
some instances to reach conventional statistical signifi-
cance of 0.05. As with diabetes, there were decreased
odds of stillbirth associated with hypertensive disorders
at gestational ages less than 28 weeks for Indigenous
women, and increased odds at term (Additional file 1:
Table S3).
Antepartum haemorrhage
Antepartum haemorrhage was strongly associated with
stillbirth for most gestational age groups and for both
Indigenous and non-Indigenous women. Among non-In-
digenous women, odds of stillbirth for antepartum haem-
orrhage was higher at 33–36 weeks (aOR 17.9, 95 % CI
13.1–24.4) compared to odds at less than 28 weeks or at
term (Table 3). Compared to non-Indigenous women,
there were decreased odds of stillbirth at 24–27 weeks
(aOR 0.56, 95 % CI 0.33–0.96) but increased odds of
stillbirth at 37+ weeks (aOR 1.53, 95 % CI 1.07–2.21)
(Additional file 1: Table S3).
Small-for-gestational age (SGA)
There were significantly increased odds of stillbirth asso-
ciated with SGA from 24 weeks gestation onwards for
Indigenous women; and at all gestational age groups for
non-Indigenous women (Table 3). Indigenous women
had decreased odds of stillbirth associated with SGA at
gestational ages less than 28 weeks compared with
non-Indigenous women, but there was no difference in
stillbirth risk at 28 weeks or older (Additional file 1:
Table S3).
Discussion
Main findings
This study found increased odds of stillbirth associated
with pre-existing diabetes, pre-existing hypertension, ante-
partum haemorrhage and SGA across most gestational
age groups for both Indigenous and non-Indigenous
women after adjusting for potential confounders. There
were mixed results for pre-eclampsia/eclampsia and
gestational diabetes. At less than 27 weeks, there were
decreased odds of stillbirth associated with diabetes,
pre-existing hypertension and SGA for Indigenous
compared with non-Indigenous women. Conversely,
the odds of stillbirth for diabetes, hypertension and
antepartum haemorrhage were 1 ½ times higher at term
for Indigenous women as non-Indigenous women. The
protective effect observed at lower gestational ages may
be due to detection bias or differing causes of stillbirth;
higher rates of spontaneous preterm birth have been
Table 3 Gestational age-specific risk of stillbirth by medical condition and Indigenous status
Conditions Indigenous (n = 20,273 births)
Adjusted Odds Ratios (95 % Confidence Intervals)
20–23 weeks 24–27 weeks 28–32 weeks 33–36 weeks 37–42+ weeks
Pre-existing diabetesa,c 1.42 (0.17–11.6) 3.15 (0.31–31.7) 7.81 (1.28–47.8) 19.0 (5.30–68.4) 15.4 (4.79–49.2)
Gestational diabetesa,c - - - 0.68 (0.09–5.32) 0.93 (0.22–4.01)
Pre-existing hypertension b,c 2.27 (0.27–18.8) 5.62 (0.55–57.7) 13.2 (2.07–84.5) 1.35 (0.14–12.8) 1.49 (0.15–14.8)
Pre-Eclampsia/Eclampsia c 0.70 (0.09–5.14) 1.59 (0.21–12.2) - 1.92 (0.24–15.2) 3.32 (0.79–14.0)
Antepartum haemorrhagea 18.1 (9.91–33.1) 14.2 (5.14–39.4) 31.2 (11.9–81.6) 2.53 (0.31–20.3) 17.1 (7.28–40.0)
Small-for-gestational age 1.30 (0.67–2.52) 3.32 (1.31–8.44) 7.04 (2.70–18.4) 3.05 (1.16–8.02) 2.10 (1.08–4.08)
Conditions Non-Indigenous (n = 340,714 births)
Adjusted Odds Ratios (95 % Confidence Intervals)
20–23 weeks 24–27 weeks 28–32 weeks 33–36 weeks 37–42+ weeks
Pre-existing diabetesa 0.90 (0.21–3.94) 3.23 (0.98–10.7) 1.33 (0.18–9.64) 7.68 (3.36–17.6) 6.77 (3.47–13.2)
Gestational diabetesa 0.47 (0.21–1.06) 0.76 (0.31–1.87) 1.25 (0.61–2.56) 1.94 (1.14–3.32) 1.29 (0.84–1.97)
Pre-existing hypertension b 7.27 (4.18–12.6) 6.59 (2.99–14.6) 3.35 (1.05–10.7) 2.54 (0.80–8.11) 1.29 (0.41–4.04)
Pre-eclampsia/Eclampsia 0.99 (0.51–1.94) 6.40 (4.14–9.91) 5.55 (3.43–8.99) 2.00 (0.94–4.26) 2.77 (1.65–4.66)
Antepartum haemorrhagea 9.03 (7.21–11.3) 7.99 (5.67–11.3) 12.8 (9.25–17.9) 17.9 (13.1–24.4) 7.95 (5.85–10.8)
Small-for-gestational age 3.73 (3.00–4.64) 6.43 (4.78–8.67) 3.85 (2.77–5.33) 3.49 (2.50–4.87) 3.72 (2.91–4.74)
Regression models adjusted for maternal age, smoking status, remoteness, substance use, gender, gravidity, hospital accommodation status, assisted conception
use, socioeconomic status, marital status, number of antenatal care visits
aModels additionally adjusted for pre-existing hypertension
bThese models additionally adjusted for pre-existing diabetes
cExact logistic regression model
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reported for Indigenous women [13]. Likewise, the in-
creased odds of stillbirth may reflect the impact of
lower levels of antenatal care such as decreased detec-
tion of SGA and suboptimal diabetes management. Few
studies have assessed gestational age-specific stillbirth
risk using the population-at-risk approach within this
study population [14]. The profile of all-cause stillbirth
risk for both groups of women was similar to profiles
reported in populations in USA [15]. However, the
overall magnitude of risk for Indigenous women was
about twice that of non-Indigenous women.
We acknowledge that the study was underpowered to
detect interactions between Indigenous status and still-
birth risk factors which may have indicated differential
effects of risk factors within the two groups of women.
Diabetes
We found increased odds of stillbirth associated with
pre-existing diabetes from 33 weeks onwards for both
groups of women. Similar findings of increased risk of
stillbirth due to pre-existing diabetes from 32 weeks on-
wards have been reported elsewhere [16, 17]. The one
and a half fold disparity in the magnitude of stillbirth
risk between Indigenous and non-Indigenous women at
term mirrors higher rates of pre-existing diabetes among
Indigenous women in our study (1.3 % versus 0.5 %).
Similarly, our finding of increased odds of stillbirth due
to gestational diabetes from 28 weeks onwards among
non-Indigenous women concurs with Hutcheon and col-
leagues [18]. While the prevalence of gestational diabetes
have been reported to be higher among Indigenous
women, the rate of increase of gestational diabetes over
time was found to be greater among non-Indigenous
women [4].
Current management for pre-existing diabetes includes
strict glycaemic control, pre-conceptual folate supplemen-
tation, cessation of oral hypoglycaemic agents, diabetes
complication review, periodic ultrasound scans for fetal
morphology (18–20 weeks), cardiac views (24 weeks), fetal
growth (28–30 and 34–36 weeks) [19]. The International
Association of Diabetes and Pregnancy Study Group rec-
ommend screening all women at their first antenatal visit
for gestational diabetes or previously undiagnosed pre-
existing diabetes [20]; however, a tiered approach with
early screening of women at high risk or with multiple risk
factors is recommended in Australia [21]. Perinatal mor-
tality audits in high income countries have identified poor
glycaemic control [22, 23] and inadequate screening
among women at risk [24] as contributing to stillbirth.
Conversely, pre-pregnancy counselling has been found to
significantly lower the risk of major congenital anomalies
associated with diabetes during pregnancy (RR 0.36, 95 %
CI 0.22–0.59; absolute risk 2.1 % versus 6.5 %) [21]. Pre-
conception care was found to reduce perinatal mortality
while optimal vs suboptimal serum blood glucose con-
trol was associated with reduced perinatal mortality
(RR 0.40, 95 % CI 0.25–0.63) but not stillbirth (RR 0.51
95 % CI 0.14–1.88) [25]. Our findings highlight the
need for early initiation of monitoring of women with
pre-existing diabetes, especially for Indigenous women;
and early identification and management of gestational
diabetes.
Antepartum haemorrhage
We found increased risk of stillbirth associated with
antepartum haemorrhage at all gestational age groups
assessed; and the magnitude of risk for Indigenous
women was 1 ½ times higher than for non-Indigenous
women at term. Despite differences in methodology,
similar magnitude of risk has been reported in popula-
tion based studies from Canada and USA with adjusted
odds ratios ranging from 11.40-18.90 for stillbirth asso-
ciated with placental abruption in births of at least
20 weeks [26, 27]. The disparity in risk seen between
Indigenous and non-Indigenous women may be a re-
flection of higher prevalence of risk factors for placenta
praevia and abruption such as maternal smoking
(52.7 % vs 16.6 %), substance use (1.7 % vs 0.5 %) and
small for gestational age (15.2 % vs 8.4 %). At present,
there is limited evidence for the prediction or preven-
tion of abruption; and antepartum haemorrhage usually
constitutes a sudden obstetric emergency. The mainstay
of management for antepartum haemorrhage includes:
assessment of maternal and fetal condition, prompt
resuscitation if required and early delivery if there is
fetal distress or the baby is suitably mature [28, 29]. It is
estimated that up to 70 % of antepartum haemorrhage
cases occur in apparently low risk pregnancies [30].
Small-for-gestational age (SGA)
We found increased odds of stillbirth associated with
SGA from 24 weeks onwards for both Indigenous and
non-Indigenous women; and similar findings have been
reported elsewhere [16]. Although not reflected in the
stillbirth odds, there was a higher prevalence of SGA
among Indigenous women in this study (15.2 % vs
8.4 %), similar to reports from the Northern Territory
(Indigenous 11.9 % vs non-Indigenous 5.0 %) [31].
SGA has been used as a proxy for fetal growth re-
striction and undetected fetal growth restriction has
been identified as a significant potentially modifiable
risk factor for stillbirth [32]. There are currently no
antenatal interventions to treat fetal growth restriction
and the mainstay of management is fetal monitoring to
determine the optimal timing for delivery (balancing
risks and benefits of adverse fetal outcomes against
morbidity and mortality associated with early delivery
at a given gestational age) [33]. Management of SGA
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involves accurate determination of gestational age and ser-
ial monitoring of fetal growth (using symphysis-fundal
height measurement or ultrasound biometry). However,
controversy exists over the accuracy of symphysis-fundal
height measurement especially in obese women [34] and
the use of customised growth charts due to lack of high
level evidence [35]. A number of interventions have been
found to be effective in the prevention of SGA among
women at increased risk, including: antiplatelet agents,
smoking cessation, progesterone therapy, anti-thrombotic
therapy and interventionist care in severe pre-eclampsia
[36]. Further studies are needed into preventive strategies
for SGA that also include pre-eclampsia and preterm birth
[36], as well as investigating the serious adverse effects of
antenatal antithrombotic therapies [37].
Equity in access to antenatal care
Overall, this study highlights the importance of optimal
maternal health prior to pregnancy as well as early initi-
ation of high quality antenatal care in the context of con-
tinued disparity in risk of stillbirth among Indigenous and
non-Indigenous women. Equity in access to antenatal care
services and their utilisation is important to addressing
disparities in health outcomes for all women, particularly
Indigenous women [38]. Indigenous women in our study
were more likely to have fewer antenatal care visits, a
finding supported by others [2, 13]. Limited availability of
culturally appropriate services may affect attendance for
antenatal care; for example there were on average 5.5
antenatal care visits within mainstream services versus
10.5 visits within community controlled service settings
for Indigenous women [39]. Active efforts to ensure ap-
propriate and responsive care in the clinical environment
both at the level of the individual health practitioner and
within mainstream health care services are essential to
reduce or eliminate social barriers to accessing health care.
Embedding cultural competence in continuing organisa-
tional quality improvement processes has been shown to
enhance health outcomes for Indigenous people [40]. This
is especially important for Indigenous women who seek
care within mainstream health services.
The Australian government has recognised the im-
portance of maternal and child health to the “Closing
the Gap” initiative and has prioritised maternal and
child health [41]. It has been shown that an investment
in stillbirth prevention provides a three-fold return in
terms of maternal, neonatal and child health [42]. While
there has been continued support for Aboriginal and
Torres Strait Islander community controlled health cen-
tres and their Mums and Bubs centres, many health and
lifestyle modification programs have been defunded. De-
clines seen in smoking and under-5 child mortality rates
are further evidence for the need to maintain funding for
successful lifestyle modification programs and antenatal
care services operated by community controlled health
services [41]. More broadly, access to primary care ser-
vices is critical to reducing health inequity and policies
that undermine universal health care pose a significant
threat to this goal by presenting further financial barriers
that are likely to disproportionately affect the most vulner-
able [43].
Conclusions
This study highlights the gestational age specific still-
birth risk associated with diabetes, hypertension, ante-
partum haemorrhage and small for gestational age. It
also highlights the disparity in stillbirth risk between In-
digenous and non-Indigenous women at term and the
need to prioritise early detection and management of
these conditions and to work with women before, during
and between pregnancies. Improving access to and util-
isation of appropriate and responsive healthcare may
help to address disparities in stillbirth risk for Indigen-
ous women. Larger population-based studies are needed
to re-evaluate whether there are differences in the effect
of risk factors on stillbirth risk among Indigenous and
non-Indigenous women.
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